ELV catalysts
Catalysts and events linked to ELV, newest first.
ELV stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven 2026-09-14 · Mixed | managed care sector multiple reassessment | Elevance Health faces similar Medicare Advantage utilization and pricing dynamics. | Not recorded |
| UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21% 2026-09-05 · Up | managed care industry utilization cost normalization | Cost easing at UNH signals sector-wide moderation in claims pressure. | Not recorded |
Do these developments change your position?
Review ELV alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
See today's live cards
2 live catalysts on ELV are in Desk now. Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.
DateCardAvg 5d
- 2026-09-14Centene Restructures Medicare Advantage Footprint to Target 2027 Margin BreakevenCNC ELV UNH-3.97%
- 2026-09-05UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21%ELV HUM UNH-3.42%
- 2026-09-05UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21%ELV HUM UNH-3.42%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.